Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Medication risk checklist for older adults (LOTTA) - development and validation of a self-assessment tool

M. Dimitrow, R. Saarenmaa, M. Airaksinen, G. Hassan, E. Puumalainen, M. Pitrová, SL. Kivelä, D. Fialová, J. Puustinen, T. Toivo

. 2023 ; 55 (2) : 2287707. [pub] 20231130

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24001304

BACKGROUND: Patient safety strategies highlight patients' own active involvement in ensuring medication safety. A prerequisite for involving patients in their medication therapy is having tools that can assist them in ensuring safe medicine use. Older home-dwelling adults with multiple medications are at high risk for medication-related problems, yet only a few age-specific patient self-administered medication risk screening tools exist. This study aimed to develop, validate, and assess the feasibility of a self-administered medication risk checklist for home-dwelling older adults ≥65 years. MATERIALS AND METHODS: The draft checklist was formed based on a validated practical nurse-administered Drug Related Problem Risk Assessment Tool supplemented with findings from two systematic literature reviews. The content validity of the draft checklist was determined by a three-round Delphi survey with a panel of 19 experts in geriatric care and pharmacotherapy. An agreement of ≥80% was required. A feasibility assessment (i.e. understandability of the items, fill-out time of the checklist) of the content-validated checklist was conducted among older adults ≥65 years (n = 87) visiting community pharmacies (n = 4). Data were analysed using qualitative content analysis. RESULTS: The final validated and feasibility-tested Medication Risk Checklist (LOTTA) for home-dwelling older adults consists of eight items screening the highest priority systemic risks (three items), potentially drug-induced symptoms (one item), adherence, and self-management problems (four items). The checklist proved feasible for self-administration, the mean fill-out time being 6.1 min. CONCLUSIONS: A wide range of potential medication risks related to the medication use process can be identified by patient self-assessment. Screening tools such as LOTTA can enhance early detection of potential medication risks and risk communication between older adults and their healthcare providers. A wider and more integrated use of the checklist could be facilitated by making it electronically available as part of the patient information systems.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24001304
003      
CZ-PrNML
005      
20260106123953.0
007      
ta
008      
240109s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/07853890.2023.2287707 $2 doi
035    __
$a (PubMed)38035545
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Dimitrow, Maarit $u Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland $1 https://orcid.org/0009000481990700
245    10
$a Medication risk checklist for older adults (LOTTA) - development and validation of a self-assessment tool / $c M. Dimitrow, R. Saarenmaa, M. Airaksinen, G. Hassan, E. Puumalainen, M. Pitrová, SL. Kivelä, D. Fialová, J. Puustinen, T. Toivo
520    9_
$a BACKGROUND: Patient safety strategies highlight patients' own active involvement in ensuring medication safety. A prerequisite for involving patients in their medication therapy is having tools that can assist them in ensuring safe medicine use. Older home-dwelling adults with multiple medications are at high risk for medication-related problems, yet only a few age-specific patient self-administered medication risk screening tools exist. This study aimed to develop, validate, and assess the feasibility of a self-administered medication risk checklist for home-dwelling older adults ≥65 years. MATERIALS AND METHODS: The draft checklist was formed based on a validated practical nurse-administered Drug Related Problem Risk Assessment Tool supplemented with findings from two systematic literature reviews. The content validity of the draft checklist was determined by a three-round Delphi survey with a panel of 19 experts in geriatric care and pharmacotherapy. An agreement of ≥80% was required. A feasibility assessment (i.e. understandability of the items, fill-out time of the checklist) of the content-validated checklist was conducted among older adults ≥65 years (n = 87) visiting community pharmacies (n = 4). Data were analysed using qualitative content analysis. RESULTS: The final validated and feasibility-tested Medication Risk Checklist (LOTTA) for home-dwelling older adults consists of eight items screening the highest priority systemic risks (three items), potentially drug-induced symptoms (one item), adherence, and self-management problems (four items). The checklist proved feasible for self-administration, the mean fill-out time being 6.1 min. CONCLUSIONS: A wide range of potential medication risks related to the medication use process can be identified by patient self-assessment. Screening tools such as LOTTA can enhance early detection of potential medication risks and risk communication between older adults and their healthcare providers. A wider and more integrated use of the checklist could be facilitated by making it electronically available as part of the patient information systems.
650    _2
$a lidé $7 D006801
650    _2
$a senioři $7 D000368
650    12
$a sebezhodnocení (psychologie) $7 D012647
650    12
$a kontrolní seznam $7 D057189
650    _2
$a zdravotnický personál $7 D006282
650    _2
$a bezpečnost pacientů $7 D061214
655    _2
$a časopisecké články $7 D016428
700    1_
$a Saarenmaa, Roosa $u Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
700    1_
$a Airaksinen, Marja $u Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland $1 https://orcid.org/0000000260775671
700    1_
$a Hassan, Ghada $u Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland $1 https://orcid.org/000000034623995X
700    1_
$a Puumalainen, Emmi $u Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland $1 https://orcid.org/0000000177410890
700    1_
$a Pitrová, Markéta $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Prague, Czech Republic $u Clinical Pharmacy Department, University Hospital Královské Vinohrady, Prague, Czech Republic $7 xx0339266
700    1_
$a Kivelä, Sirkka-Liisa $u Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland $u Faculty of Medicine, Department of Clinical Medicine, Unit of Family Medicine, University of Turku and Turku University Hospital, Turku, Finland $1 https://orcid.org/0009000603906926
700    1_
$a Fialová, Daniela $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Prague, Czech Republic $u Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000156389690
700    1_
$a Puustinen, Juha $u Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland $u Service Unit of Neurology, Satasairaala Central Hospital, Wellbeing County of Satakunta, Pori, Finland $1 https://orcid.org/0000000240331539
700    1_
$a Toivo, Terhi $u Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland $1 https://orcid.org/0000000183572714
773    0_
$w MED00009195 $t Annals of medicine $x 1365-2060 $g Roč. 55, č. 2 (2023), s. 2287707
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38035545 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20260106123946 $b ABA008
999    __
$a ok $b bmc $g 2049747 $s 1210998
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 55 $c 2 $d 2287707 $e 20231130 $i 1365-2060 $m Annals of medicine $n Ann Med $x MED00009195
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace